Direkt zum Inhalt

Ahrens, Norbert ; Schewior, L. ; Garbe, E. ; Kiesewetter, H. ; Salama, A.

Massive haemolysis after intramuscular diclofenac in a patient who apparently tolerated oral medication

Ahrens, Norbert , Schewior, L., Garbe, E., Kiesewetter, H. und Salama, A. (2004) Massive haemolysis after intramuscular diclofenac in a patient who apparently tolerated oral medication. Vox sanguinis 86 (1), S. 71-74.

Veröffentlichungsdatum dieses Volltextes: 22 Dez 2021 10:00
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.51263


Zusammenfassung

Background and Objectives Administration of diclofenac may lead to immune haemolytic anaemia (IHA) owing to the presence of drug-dependent antibodies and/or autoantibodies. A relationship with oral or intramuscular drug administration is unknown. Here, we describe a patient who apparently tolerated oral diclofenac but developed severe IHA following intramuscular injection of the ...

Background and Objectives
Administration of diclofenac may lead to immune haemolytic anaemia (IHA) owing to the presence of drug-dependent antibodies and/or autoantibodies. A relationship with oral or intramuscular drug administration is unknown. Here, we describe a patient who apparently tolerated oral diclofenac but developed severe IHA following intramuscular injection of the drug.

Patients and Methods
A 66-year-old-female was admitted to hospital because of jaundice and nausea, which were initially presumed to be manifestations of a postcholecystectomy syndrome. The patient soon developed haemolysis and renal failure. Although the symptoms and signs were suggestive of autoimmune haemolytic anaemia (AIHA), the patient had diclofenac-induced IHA.

Results
Serological testing, including detection of drug-dependent antibodies, was performed using standard techniques. The patient's serum was found to contain a highly reactive diclofenac-dependent red cell antibody of the immune complex type (titre 256 000). She recovered after 7 weeks of treatment with prednisolone, blood transfusions, haemodialysis and plasma exchange.

Conclusions
Diclofenac-induced IHA should always be considered when a patient on diclofenac develops haemolysis.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftVox sanguinis
Verlag:Wiley
Band:86
Nummer des Zeitschriftenheftes oder des Kapitels:1
Seitenbereich:S. 71-74
Datum30 Januar 2004
InstitutionenMedizin > Lehrstuhl für Klinische Chemie und Laboratoriumsmedizin
Identifikationsnummer
WertTyp
10.1111/j.0042-9007.2004.00389.xDOI
Stichwörter / Keywordsdiclofenac, drug-dependent antibodies, drug-induced haemolysis, immunehaemolytic anaemia
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenZum Teil
Dokumenten-ID51263

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben